In that study, we were unable to identify any clinically meaningful association related to the presence of these polymorphisms, with the exception of an association with anti-gp210 antibody [18], a prognostically relevant autoantibody marker of PBC [50–52]. This evidence concerns the gene NUP210 and primary biliary cholangitis.